ACADIA PHARMACEUTICALS INC
ACAD
28 insider filings · Latest: Aug 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | Nov 10 10:59 PM | James M Daly | Proposed Sale | 30,000 | $22.37 | $671.0K | — | View → |
| Aug 18, 2025 | Aug 18 8:31 PM | Schneyer Mark C. | Proposed Sale | 22,000 | $25.33 | $557.3K | — | View → |
| Jun 4, 2025 | Jun 4 8:35 PM | LAURA BREGE | Proposed Sale | 14,446 | $21.78 | $314.6K | — | View → |
| May 16, 2025 | May 16 9:10 PM | Schneyer Mark C. | Proposed Sale | 2,000 | $17.60 | $35.2K | — | View → |
| May 16, 2025 | May 16 9:06 PM | Kihara James | Proposed Sale | 4,000 | $17.60 | $70.4K | — | View → |
| Mar 5, 2025 | Mar 6 5:17 PM | GAROFALO ELIZABETH A. | Proposed Sale | 4,919 | $18.23 | $89.7K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Aug 7 10:00 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Option Exercise | 14,292 | $17.84 | 60,423(D) | View → |
| Aug 5, 2026 | Aug 7 10:00 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Option Exercise | 5,849 | $17.84 | 74,715(D) | View → |
| Jul 29, 2026 | Jul 31 10:00 PM | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | Option Exercise | 32,272 | — | 32,272(D) | View → |
| May 29, 2026 | Jun 2 8:32 PM | BAKER BROS. ADVISORS LPDirector, 10% Owner | Grant/Award | 64,016 | $21.66 | 32,008(I) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Edmund HarriganDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Edmund HarriganDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Adora NduDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Adora NduDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Laura BregeDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Laura BregeDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Jonathan PooleDirector | Option Exercise | 2,010 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Jonathan PooleDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Elizabeth A. GarofaloDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Elizabeth A. GarofaloDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | James M DalyDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | James M DalyDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 1, 2026 | May 5 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Option Exercise | 2,596 | — | 2,596(D) | View → |
| May 1, 2026 | May 5 10:00 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Option Exercise | 6,815 | — | 6,815(D) | View → |
| Apr 5, 2026 | Apr 7 11:57 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Option Exercise | 5,276 | — | 0(D) | View → |
| Apr 5, 2026 | Apr 7 11:55 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Option Exercise | 2,010 | — | 0(D) | View → |
Page 1 of 2
Next →